AP453A - Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 Protein of rubella virus. - Google Patents

Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 Protein of rubella virus. Download PDF

Info

Publication number
AP453A
AP453A APAP/P/1993/000556A AP9300556A AP453A AP 453 A AP453 A AP 453A AP 9300556 A AP9300556 A AP 9300556A AP 453 A AP453 A AP 453A
Authority
AP
ARIPO
Prior art keywords
peptide
rubella
analogues
bch
mixture
Prior art date
Application number
APAP/P/1993/000556A
Other languages
English (en)
Other versions
AP9300556A0 (en
Inventor
Maan Zrein
Martial Lacroix
Original Assignee
Biochem Immunosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochem Immunosystems Inc filed Critical Biochem Immunosystems Inc
Publication of AP9300556A0 publication Critical patent/AP9300556A0/xx
Application granted granted Critical
Publication of AP453A publication Critical patent/AP453A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36211—Rubivirus, e.g. rubella virus
    • C12N2770/36222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
APAP/P/1993/000556A 1992-08-07 1993-08-06 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 Protein of rubella virus. AP453A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/927,071 US5427792A (en) 1989-08-23 1992-08-07 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus

Publications (2)

Publication Number Publication Date
AP9300556A0 AP9300556A0 (en) 1993-10-31
AP453A true AP453A (en) 1996-01-20

Family

ID=25454125

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1993/000556A AP453A (en) 1992-08-07 1993-08-06 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 Protein of rubella virus.

Country Status (13)

Country Link
US (1) US5427792A (de)
EP (1) EP0656013B1 (de)
JP (1) JP3492686B2 (de)
AP (1) AP453A (de)
AT (1) ATE192163T1 (de)
AU (1) AU690070B2 (de)
CA (1) CA2141670C (de)
DE (1) DE69328488T2 (de)
ES (1) ES2145055T3 (de)
IL (1) IL106592A (de)
PT (1) PT656013E (de)
WO (1) WO1994003490A1 (de)
ZA (1) ZA935642B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238660A1 (en) * 1998-05-22 1999-11-22 Janet Chantler Gene sequences of rubella virus associated with attenuation
WO2000033081A1 (en) * 1998-12-01 2000-06-08 Viral Antigens, Inc. IMPROVED SPECIFICITY IN THE DETECTION OF ANTI-RUBELLA IgM ANTIBODIES
BR102018075339A2 (pt) * 2018-12-06 2021-11-16 Fundação Oswaldo Cruz Proteína recombinante, sequência de dna sintético, vetor de expressão, célula hospedeira, composição, kit para diagnóstico de rubéola, uso de pelo menos uma proteína recombinante, e, métodos para produzir uma proteína recombinante e para diagnóstico de rubéola
CN110423272A (zh) * 2019-08-15 2019-11-08 捷敏(天津)生物技术有限公司 一种新的抗风疹病毒膜蛋白e1的抗体及其应用技术领域

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002748A1 (en) * 1989-08-23 1991-03-07 Iaf Biochem International Inc. Rubella e1 peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003206A1 (en) * 1985-11-25 1987-06-04 Quash Gerard A Modified viral glycoproteins, diagnostic and therapeutic uses therefore
GB2206587A (en) * 1987-07-08 1989-01-11 London Biotechnology Ltd Rubella e1 glycoprotein antigens
GB9201139D0 (en) * 1992-01-20 1992-03-11 Connaught Lab Synthetic peptides for a rubella vaccine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002748A1 (en) * 1989-08-23 1991-03-07 Iaf Biochem International Inc. Rubella e1 peptides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF VIROLOGY vol. 65 , 1991 , BALTIMORE,USA pages 3986 - 3994 WOLINSKY ET AL 'MONOCLONAL ANTIBODY-DEFINED EPITOPE MAP OF EXPRESSED RUBELLA VIRUS PROTEIN DOMAINS' *

Also Published As

Publication number Publication date
ATE192163T1 (de) 2000-05-15
PT656013E (pt) 2000-10-31
AU4693493A (en) 1994-03-03
WO1994003490A1 (en) 1994-02-17
ZA935642B (en) 1995-02-06
AU690070B2 (en) 1998-04-23
CA2141670C (en) 2007-03-06
CA2141670A1 (en) 1994-02-17
DE69328488T2 (de) 2000-11-30
ES2145055T3 (es) 2000-07-01
EP0656013B1 (de) 2000-04-26
JPH08502724A (ja) 1996-03-26
AP9300556A0 (en) 1993-10-31
US5427792A (en) 1995-06-27
EP0656013A1 (de) 1995-06-07
JP3492686B2 (ja) 2004-02-03
IL106592A (en) 2001-01-11
IL106592A0 (en) 1993-12-08
DE69328488D1 (de) 2000-05-31

Similar Documents

Publication Publication Date Title
JP3477198B2 (ja) Ｃ型肝炎ウィルス（ｈｃｖ）に対する抗体の検出のためのペプチド及びその混合物
EP0330359A2 (de) Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
WO1987007616A1 (en) Peptides involved in the pathogenesis of hiv infection
EP0538283B2 (de) Synthetische peptide und mischungen davon zum nachweis der gegen hiv-gerichteten antikörper
EP0491713B1 (de) Rubella-e1 und c peptide
JP3851761B2 (ja) Ｈｉｖ抗体を検出するための合成ペプチド及びその混合物
IE871289L (en) Peptides, antibodies, vaccines and assay methods.
JP3390002B2 (ja) Ｈｔｌｖ―ｉおよびｈｔｌｖ―ｉｉウイルスに対する抗体を検出するためのペプチドおよびアナログおよびその混合物
CA1271717A (en) Polypeptides useful in vaccination against enteroviruses
US5017688A (en) Peptides involved in the pathogenesis of HIV infection
AP453A (en) Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 Protein of rubella virus.
NZ235538A (en) Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
CA1338028C (en) Synthetic peptide antigens for the detection of hiv-1 infection
MXPA97009271A (en) Diagnosis of, and vaccination against, in positive thread rna virus using an isolated polypeptide, do not process